Tom Truong

1.5k total citations
12 papers, 1.0k citations indexed

About

Tom Truong is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Tom Truong has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Ophthalmology and 4 papers in Oncology. Recurrent topics in Tom Truong's work include Cancer-related Molecular Pathways (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Glaucoma and retinal disorders (2 papers). Tom Truong is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Glaucoma and retinal disorders (2 papers). Tom Truong collaborates with scholars based in United States, France and Switzerland. Tom Truong's co-authors include Marcia Belvin, Lori S. Friedman, Klaus P. Hoeflich, Lesley Murray, Elizabeth M. Blackwood, Zachary Boyd, Wei Zhou, Tom Januario, Elizabeth A. Punnoose and Guy Cavet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Cancer Research.

In The Last Decade

Tom Truong

10 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom Truong United States	8	709	393	231	137	115	12	1.0k
Amanda R. Moore United States	7	747 1.1×	375 1.0×	153 0.7×	150 1.1×	137 1.2×	10	1.1k
Hanhua Huang United States	9	595 0.8×	182 0.5×	262 1.1×	95 0.7×	126 1.1×	14	869
Keiichi Aomatsu Japan	15	510 0.7×	254 0.6×	194 0.8×	96 0.7×	54 0.5×	23	817
Irene Rodríguez‐Hernández Spain	15	481 0.7×	279 0.7×	161 0.7×	76 0.6×	93 0.8×	21	877
Marcus Bosenberg United States	13	801 1.1×	384 1.0×	322 1.4×	123 0.9×	188 1.6×	20	1.2k
Bryan W. Johnson United States	8	738 1.0×	326 0.8×	108 0.5×	109 0.8×	119 1.0×	15	1.1k
Huwate Yeerna United States	12	468 0.7×	229 0.6×	127 0.5×	74 0.5×	96 0.8×	15	762
Ángel Santiago Mexico	9	697 1.0×	325 0.8×	261 1.1×	69 0.5×	137 1.2×	16	908
Mamunur Rashid United Kingdom	14	491 0.7×	248 0.6×	220 1.0×	89 0.6×	116 1.0×	19	817
Jeff C. Liu Canada	19	897 1.3×	660 1.7×	434 1.9×	197 1.4×	142 1.2×	25	1.4k

Countries citing papers authored by Tom Truong

Since Specialization

Citations

This map shows the geographic impact of Tom Truong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Truong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Truong more than expected).

Fields of papers citing papers by Tom Truong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Truong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Truong. The network helps show where Tom Truong may publish in the future.

Co-authorship network of co-authors of Tom Truong

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Truong. A scholar is included among the top collaborators of Tom Truong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Truong. Tom Truong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Gu, Xiaowu, Tom Truong, Tae‐Hoon Kim, et al.. (2025). Evaluating the Optic Nerve Crush Model to Understand the Function of Microglia in Glaucoma Neuroprotection. Investigative Ophthalmology & Visual Science. 66(12). 56–56.

Katschke, Kenneth J., Tom Truong, Victoria C. Pham, et al.. (2025). HTRA1-dependent proteolysis induces age-related retinal degeneration and exacerbates choroidal neovascularization. Disease Models & Mechanisms. 18(10).

Jones, Melissa K., Luz D. Orozco, Qin Han, et al.. (2023). Integration of human stem cell-derived in vitro systems and mouse preclinical models identifies complex pathophysiologic mechanisms in retinal dystrophy. Frontiers in Cell and Developmental Biology. 11. 1252547–1252547. 2 indexed citations

Katschke, Kenneth J., Hongkang Xi, Christian L. Cox, et al.. (2018). Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy. Scientific Reports. 8(1). 7348–7348. 52 indexed citations

Xi, Hongkang, Kenneth J. Katschke, Yun Li, et al.. (2016). IL-33 amplifies an innate immune response in the degenerating retina. The Journal of Experimental Medicine. 213(2). 189–207. 75 indexed citations

Estrada, Anthony A., Daniel G. Shore, Elizabeth Blackwood, et al.. (2013). Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR). Journal of Medicinal Chemistry. 56(7). 3090–3101. 25 indexed citations

McCleland, Mark L., Adam S. Adler, Yonglei Shang, et al.. (2012). An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer. Cancer Research. 72(22). 5812–5823. 150 indexed citations

Adler, Adam S., Mark L. McCleland, Tom Truong, et al.. (2012). CDK8 Maintains Tumor Dedifferentiation and Embryonic Stem Cell Pluripotency. Cancer Research. 72(8). 2129–2139. 80 indexed citations

Vijapurkar, Ulka, Liliane Robillard, Michael Degtyarev, et al.. (2012). mTOR kinase inhibitor potentiates apoptosis of PI3K and MEK inhibitors in diagnostically defined subpopulations. Cancer Letters. 326(2). 168–175. 6 indexed citations

10.

Ong, Christy C., Adrian M. Jubb, Peter M. Haverty, et al.. (2011). Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells. Proceedings of the National Academy of Sciences. 108(17). 7177–7182. 170 indexed citations

11.

Hoeflich, Klaus P., Carol O’Brien, Zachary Boyd, et al.. (2009). In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models. Clinical Cancer Research. 15(14). 4649–4664. 385 indexed citations

12.

Yao, Evelyn, Wei Zhou, Si Tuen Lee-Hoeflich, et al.. (2009). Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab. Clinical Cancer Research. 15(12). 4147–4156. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact